Procept Overview
- Year Founded
-
1985
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Procept General Information
Description
Developer of therapeutic drugs to manage diseases of the immune system. The company focuses on drug product development for AIDS, autoimmune disease, organ transplant rejection and allergies.
Contact Information
Corporate Office
- 840 Memorial Drive
- Cambridge, MA 02139
- United States
Corporate Office
- 840 Memorial Drive
- Cambridge, MA 02139
- United States
Procept Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 28-Jan-2000 | Completed | Generating Revenue | |||
| 2. IPO | 17-Feb-1994 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 22-Aug-1990 | $9.2M | $9.2M | Completed | Product Development |
Procept Patents
Procept Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2108099-A | Immunosuppressive agents | Inactive | 30-Jan-1998 | ||
| WO-1999038846-A1 | Immunosuppressive agents | Inactive | 30-Jan-1998 | ||
| ES-2224385-T3 | Composition of condensation polymer to prevent pregnancy. | Inactive | 01-May-1997 | ||
| AU-7260198-A | Condensation polymer composition for preventing pregnancy | Active | 01-May-1997 | ||
| AU-732693-B2 | Condensation polymer composition for preventing pregnancy | Inactive | 01-May-1997 | A61K31/795 |
Procept Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bristol-Myers Squibb | Corporation | Minority | ||
| HealthCare Ventures | Venture Capital | Minority | ||
| Montgomery Medical Ventures | Venture Capital | Minority | ||
| Rho Acceleration | Venture Capital | Minority |
Procept Acquisitions (1)
Procept’s most recent deal was a Reverse Merger with HeavenlyDoor.com. The deal was made on 28-Jan-2000.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| HeavenlyDoor.com | 28-Jan-2000 | Reverse Merger | Other Services (B2C Non-Financial) |
Procept FAQs
-
When was Procept founded?
Procept was founded in 1985.
-
Where is Procept headquartered?
Procept is headquartered in Cambridge, MA.
-
What industry is Procept in?
Procept’s primary industry is Drug Discovery.
-
Is Procept a private or public company?
Procept is a Private company.
-
What is Procept’s current revenue?
The current revenue for Procept is .
-
How much funding has Procept raised over time?
Procept has raised $28.1M.
-
Who are Procept’s investors?
Bristol-Myers Squibb, HealthCare Ventures, Montgomery Medical Ventures, and Rho Acceleration have invested in Procept.
-
When was Procept acquired?
Procept was acquired on 28-Jan-2000.
-
Who acquired Procept?
Procept was acquired by HeavenlyDoor.com.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process